How can I schedule an appointment for IV therapy
It gets really, really frustrating to have to justify what I want to do all the time just because of money, Dushay said
Apovian said she is hopeful that demand for non-FDA-approved obesity medication will dissipate as insurance coverage and access for therapies improves, and that recent findings on how incretin-based agents benefit cardiovascular and renal health will push stakeholders to make sure all people who need a drug will be able to access and afford it
Taylor Kohn, M.D., is a fellow in male reproductive medicine and surgery at Baylor College of Medicine James Staheli, D.O., is the medical director for Broad Health and a family medicine doctor specializing in hormone treatment for men
Retatrutide The Novel New Weight-loss Peptide awaiting FDA approval The landscape of weight management is evolving rapidly, with researchers developing increasingly sophisticated approaches to help people achieve sustainable results